Academics

A Randomized,
Crossover Pilot to Examine the Acute Impact of Veillonella Supplementation on Exercise and Lactate Responses

A Randomized,
Crossover Pilot to Examine the Acute Impact of Veillonella Supplementation on Exercise and Lactate Responses

Academics NAVIGATION

LU IRB#: IRB-22-60
PI: Chad Kerksick, PhD

Description of Study

The purpose of this study is to examine the impact of a probiotic strain, Veillonella atypica, on exercise performance and lactate responses.

Location
Exercise and Performance Nutrition Laboratory (Fieldhouse 126)
209 S. Kingshighway
St. Charles, MO 63301

Number of Visits
6

Time Commitment
Visits 1: 60 Minutes
Visits 2-6: 45 Minutes Each

Compensation
$200 (Direct Deposit)

Point of Contact
Kristen Gross
epnl@lindenwood.edu

Research Sample Needed

  • 7 healthy, physically active males and females

Inclusion Criteria

  • In good health as determined by medical history and routine blood chemistries.
  • Age between 18 and 50.
  • Exercises > 150 mins/week.
  • Body Mass Index of 18.5-29.9 and Body Fat of 30%.
  • Normotensive (resting systolic blood pressure < 140 mm Hg and diastolic blood pressure < 90 mm Hg.
  • Normal seated, resting heart rate (< 90 beats per minute).

Exclusion Criteria

  • Diagnosed or being treated for any cardiac, respiratory, endocrine, psychiatric, musculoskeletal, renal, hepatic, neuromuscular or metabolic disease or disorder that will preclude their safe participation or contraindicate quality control over the collected data.
  • Diagnosed with or being treated for celiac disease, lactose intolerance, digestive insufficiencies, or other gastrointestinal complications such as irritable bowel syndrome, ulcerative colitis, etc.
  • Alcohol consumption (>2 standard alcoholic drinks per day or >10 drinks per week) or drug abuse or dependence.
  • Smokers or individuals who have quit smoking <6 months ago.
  • Known sensitivity to any ingredient in the test formulations.
  • Individuals on a ketogenic diet.
  • Individuals who are cognitively impaired and/or unable to give informed consent.
  • Taking a medication, probiotic, or a dietary supplement that may impact digestive or hormonal functions involved in digestion, absorption, or metabolism of nutrients.
  • Pregnant, trying to become pregnant, or nursing women.
  • Actively restricting calories or attempting to lose weight.
  • Individuals who do not participate in aerobic exercise > 2 days/week.

Are You Eligible?

Information provided here reflects current IRB approval for this research. However, this information may be subject to change and updated accordingly.